Dataset Information

Development and Evaluation of a Holistic and Mechanistic Modeling Framework for Chemical Emissions, Fate, Exposure, and Risk.

ABSTRACT:

Background

Large numbers of chemicals require evaluation to determine if their production and use pose potential risks to ecological and human health. For most chemicals, the inadequacy and uncertainty of chemical-specific data severely limit the application of exposure- and risk-based methods for screening-level assessments, priority setting, and effective management.

Objective

We developed and evaluated a holistic, mechanistic modeling framework for ecological and human health assessments to support the safe and sustainable production, use, and disposal of organic chemicals.

Methods

We consolidated various models for simulating the PROduction-To-EXposure (PROTEX) continuum with empirical data sets and models for predicting chemical property and use function information to enable high-throughput (HT) exposure and risk estimation. The new PROTEX-HT framework calculates exposure and risk by integrating mechanistic computational modules describing chemical behavior and fate in the socioeconomic system (i.e., life cycle emissions), natural and indoor environments, various ecological receptors, and humans. PROTEX-HT requires only molecular structure and chemical tonnage (i.e., annual production or consumption volume) as input information. We evaluated the PROTEX-HT framework using 95 organic chemicals commercialized in the United States and demonstrated its application in various exposure and risk assessment contexts.

Results

Seventy-nine percent and 97% of the PROTEX-HT human exposure predictions were within one and two orders of magnitude, respectively, of independent human exposure estimates inferred from biomonitoring data. PROTEX-HT supported screening and ranking chemicals based on various exposure and risk metrics, setting chemical-specific maximum allowable tonnage based on user-defined toxicological thresholds, and identifying the most relevant emission sources, environmental media, and exposure routes of concern in the PROTEX continuum. The case study shows that high chemical tonnage did not necessarily result in high exposure or health risks.

Conclusion

Requiring only two chemical-specific pieces of information, PROTEX-HT enables efficient screening-level evaluations of existing and premanufacture chemicals in various exposure- and risk-based contexts. https://doi.org/10.1289/EHP9372.

SUBMITTER: Li L

PROVIDER: S-EPMC8658982 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:Exposure to vehicular emissions has been linked to numerous adverse health effects. In response to the arising concerns, near-road monitoring is conducted to better characterize the impact of mobile source emissions on air quality and exposure in the near-road environment. An intensive measurement campaign measured traffic-related air pollutants (TRAPs) and related data (e.g., meteorology, traffic, regional air pollutant levels) in Atlanta, along one of the busiest highway corridors in the US. Given the complexity of the near-road environment, the study aimed to compare two near-road monitors, located in close proximity to each other, to assess how observed similarities and differences between measurements at these two sites inform the siting of other near-road monitoring stations. TRAP measurements, including carbon monoxide (CO) and nitrogen dioxide (NO2), are analyzed at two roadside monitors in Atlanta, GA located within 325m of each other. Both meteorological and traffic conditions were monitored to assess the temporal impact of these factors on traffic-related pollutant concentrations. The meteorological factors drove the diurnal variability of primary pollutant concentration more than traffic count. In spite of their proximity, while the CO and NO2 concentrations were correlated with similar diurnal variations, pollutant concentrations at the two closely sited monitors differed, likely due to the differences in the siting characteristics reducing the dispersion of the primary emissions out of the near-road environment. Overall, the near-road TRAP concentrations at all sites were not as elevated as seen in prior studies, supporting that decreased vehicle emissions have led to significant reductions in TRAP levels, even along major interstates. Further, the differences in the observed levels show that use of single near-road observations will not capture pollutant levels representative of the local near-road environment and that additional approaches (e.g., air quality models) are needed to characterize exposures.

Project description:In vitro neural stem cell models are widely used to model a wide range of neuropsychiatric conditions. However, how well such models correspond to in vivo brain has not been evaluated in an unbiased, comprehensive manner. We used transcriptomic analyses to compare in vitro systems to developing human fetal brain and observed strong conservation of in vivo gene expression and network architecture in differentiating primary human neural progenitor cells (phNPCs). Conserved modules are enriched in genes associated with ASD, supporting the utility of phNPCs for studying neuropsychiatric disease. We also developed and validated a machine learning approach called CoNTExT that identifies the developmental maturity and regional identity of in vitro models. We observed strong differences between in vitro models, including hiPSC-derived neural progenitors from multiple laboratories. This work provides a framework for evaluating in vitro systems and supports their value in studying the molecular mechanisms of human neurodevelopmental disease. In this GEO submission, we upload data from 5 lines of phNPCs as well as hiPSCs cultured in two different laboratories all at multiple differentiation time points. phNPCs: For each of 5 lines generated from 3 donors (15-16 PCW), two independent differentiation experiments each containing two replicates were performed and harvested at four time points (1, 4, 8, 12 wks PD; ~16 samples per line; 77 total samples). We confirmed RNA integrity by RIN score with the Agilent 2100 Bioanalyzer (mean +/- sd: 9.16 +/- 0.78). iPSC: Two hiPSC datasets were RNA profiled as part of this study. hiPSCs grown in the Kosik lab was derived from two independent, non-isogenic IPS lines: one derived from a patient carrying a mutant Tau variant G55R and one reference control. For each of these lines, two samples were harvested at each of 0, 1, 4, and 8 weeks PD (total n=16 samples). hiPSCs grown in the Gage lab were from six samples derived from 3 control lines at each of two time points (0 and 4 wk PD, total n=12 samples). Samples were randomized to microarray chip by all biological variables of interest (donor, line, passage, replicate number, differentiation week, plate date, and RIN) to control for potential batch effects.